Search Form
First, enter a politician or zip code
Now, choose a category
 

Elijah Cummings' Public Statements

Office: U.S. House (MD) - District 7, Democratic
Date Title
Nov. 13, 2014 Congress Passes Historic Bipartisan Legislation to Streamline Federal Records Reporting
Nov. 12, 2014 Letter to Chairman Rogers, Rep. Nita Lowey, Committee on Appropriations, and Chairman Andrew Crenshaw, Rep. Jose Serrano, Subcommittee on Financial Services and General Government - Postal Service Mail Processing Facilities Closing
Nov. 12, 2014 Letter to Brian Cornell, Chairman and CEO of Target Corporation - Seeking Briefings and Documents on Troubling Increase in Cyber-Attacks
Nov. 12, 2014 Baltimore Sun - Cummings Bill on White House Records Approved
Nov. 12, 2014 Letter to Wayne Smith, Chairman, President, and CEO of Community Health Systems - Seeking Briefings and Documents on Troubling Increase in Cyber-Attacks
Nov. 12, 2014 Letter to Alasdair James, President and CEO of Kmart Corporation - Seeking Briefings and Documents on Troubling Increase in Cyber-Attacks
Nov. 12, 2014 Presidential and Federal Records Act of 2014
Nov. 12, 2014 Letter to Frank Blake, Chairman and CEO of The Home Depot - Seeking Briefings and Documents on Troubling Increase in Cyber-Attacks
Nov. 12, 2014 Letter to Jonathan Nelson, CEO of Providence Equity Partners, and Jeffrey Campbell, President and CEO of Altegrity - Seeking Briefings and Documents on Troubling Increase in Cyber-Attacks
Nov. 11, 2014 Congressional Panel to Probe Generic Drug Price Hikes
Nov. 10, 2014 Letter to Patrick Donahoe, Postmaster General and CEO of the US Postal Service - Requesting Additional Information on Cyber Attack
Nov. 10, 2014 Letter to John Boehner, Speaker of the House and Nancy Pelosi, House Minority Leader - Urging Restoration of NIH Funding in Lame Duck
Nov. 4, 2014 Roll Call - For Cummings, A Higher Profile Means Getting Things Done
Nov. 3, 2014 Cummings Receives Service Award from APL Maritime
Oct. 30, 2014 Harkin, Durbin, Murphy, Cummings on Department of Education's Final Gainful Employment Rule and For-Profit Task Force Announcement
Oct. 30, 2014 Rising Generic Drug Prices Under Congressional Investigation
Oct. 29, 2014 Cummings: Merchant Marine Academy's Sexual Assault Policies Inadequate
Oct. 27, 2014 Ruppersberger, Cummings, Sarbanes Announce $10 Million Grant to Retrain Unemployed Marylanders
Oct. 27, 2014 Letter to Mary Jo White, Chairman of the Securities and Exchange Commission - Protecting Corporate Whistleblowers
Oct. 27, 2014 Cummings and Speier Respond to IG Report on Sexual Assault and Harassment at Merchant Marine Academy
Oct. 24, 2014 Hearing of the House Oversight and Government Reform Committee - The Ebola Crisis: Coordination of a Multi-Agency Response
Oct. 23, 2014 Baltimore Sun - Cummings and Maryland Democrats Launch Effort on Voting Rights
Oct. 22, 2014 Voting for Our Principles and Our Interests
Oct. 20, 2014 Letter to Gene L. Dodaro, Comptroller General of the United States - Requesting Investigation into Non-Bank Mortgage Servicing Industry
Oct. 16, 2014 Letter to Sylvia Burwell, Secretary of Health and Human Services - Staggering Increasing in the Prices Being Charged for Generic Drugs
Oct. 15, 2014 Washington Post - Federal Workers Facing Tougher Time if GOP Wins Control of the Senate
Oct. 13, 2014 Baltimore Magazine - Up Hill Climb
Oct. 10, 2014 Cummings Fights for Funding for Baltimore Healthy Start Program
Oct. 9, 2014 Think Progress - Generic Drug Prices Have Jumped 1,000 Percent And Lawmakers Want Answers
Oct. 8, 2014 Letter to Eric Holder, Attorney General of the United States - Support of an Investigation of BPD
Oct. 7, 2014 Letter to Darrell Issa, Chairman of the House Committee on Oversight and Government Reform - Requesting Hearing on Data Security Breach at JPMorgan Chase
Oct. 7, 2014 Fourteen Attorneys General Support Harkin, Durbin, Cummings Bill to Improve Federal Oversight of For-Profit College Industry
Oct. 6, 2014 Cummings Commends CMS for Improving Nursing Home Rating System
Oct. 5, 2014 CBS "Face the Nation" - Transcript: Secret Service
Oct. 3, 2014 Mikulski, Cardin, Cummings, and Baltimore Clergy Stand United in Effort to End Racial Profiling by Law Enforcement
Oct. 3, 2014 Letter to Jeh Johnson, Secretary of Homeland Security - Independent Review of Secret Service Must Assess Entire Agency
Oct. 2, 2014 The Hill - Cummings: 'I want some heads to roll'
Oct. 2, 2014 Letter to Joseph Renner, CEO of Zydus Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Dilip Shanghvi, Managing Director of Sun Pharmaceutical Industries - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Arthur Bedrosian, President and CEO of Lannett Company - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Jeffrey Aronin, Chairman and CEO of Marathon Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Heather Bresch, CEO of Mylan - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Erez Vigodman, President and CEO of Teva Pharmaceutical Industries - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Paul Campanelli, CEO of Par Pharmaceutical Companies - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Brian Lortie, President at Endo International PLC - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Carole Ben-Maimon, President of Global Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Wall Street Journal - Lawmakers Probe "Staggering' Price Hikes for Generic Drugs
Oct. 2, 2014 Letter to Jeffrey Glazer, President and CEO of Heritage Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Umang Vohra, Executive Vice President of Dr. Reddy's Laboratories LTD - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Michael Raya, President and CEO of West-Ward Pharmaceutical Corporation - Investigating Staggering Price Increases for Generic Drugs
Skip to top
Back to top